Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hampel

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Maturitas|November 22, 2005
A description of health care provision and access to treatment for women with urinary incontinence in Europe -- a five-country comparisonBrigitta Monz, Christian Hampel, Sheuli Porkess, et al.
European Urology|November 4, 2006
Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PUREBrigitta Monz, Emmanuel Chartier-Kastler, Christian Hampel, et al.
European Urology|October 20, 2006
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC studyDebra E Irwin, Ian Milsom, Steinar Hunskaar, et al.
World Journal of Urology|August 21, 2009
Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in GermanyBjörn Wefer, Birgit Ehlken, Jörn Bremer, et al.
Maturitas|November 22, 2005
Characteristics of female outpatients with urinary incontinence participating in a 6-month observational study in 14 European countriesDavid Sykes, Ramiro Castro, Montserrat Espuna Pons, et al.
European Urology|December 7, 2010
EAU guidelines on urinary incontinenceJoachim W Thüroff, Paul Abrams, Karl-Erik Andersson, et al.
Clinical Oral Investigations|August 27, 2015
Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC)Christian Thomas, Magdalena Spanidis, Christina Engel, et al.
International Urology and Nephrology|September 18, 2015
Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomyChristian Thomas, Alexander Giesswein, Michael Hainz, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|December 13, 2006
Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinenceDavid Castro-Diaz, Paulo C R Palma, Céline Bouchard, et al.
The American Journal of Pathology|February 2, 2011
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinomaFrederik C Roos, Andrew J Evans, Walburgis Brenner, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Maturitas|November 22, 2005
A description of health care provision and access to treatment for women with urinary incontinence in Europe -- a five-country comparisonBrigitta Monz, Christian Hampel, Sheuli Porkess, et al.
European Urology|November 4, 2006
Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PUREBrigitta Monz, Emmanuel Chartier-Kastler, Christian Hampel, et al.
European Urology|October 20, 2006
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC studyDebra E Irwin, Ian Milsom, Steinar Hunskaar, et al.
World Journal of Urology|August 21, 2009
Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in GermanyBjörn Wefer, Birgit Ehlken, Jörn Bremer, et al.
Maturitas|November 22, 2005
Characteristics of female outpatients with urinary incontinence participating in a 6-month observational study in 14 European countriesDavid Sykes, Ramiro Castro, Montserrat Espuna Pons, et al.
European Urology|December 7, 2010
EAU guidelines on urinary incontinenceJoachim W Thüroff, Paul Abrams, Karl-Erik Andersson, et al.
Clinical Oral Investigations|August 27, 2015
Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC)Christian Thomas, Magdalena Spanidis, Christina Engel, et al.
International Urology and Nephrology|September 18, 2015
Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomyChristian Thomas, Alexander Giesswein, Michael Hainz, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|December 13, 2006
Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinenceDavid Castro-Diaz, Paulo C R Palma, Céline Bouchard, et al.
The American Journal of Pathology|February 2, 2011
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinomaFrederik C Roos, Andrew J Evans, Walburgis Brenner, et al.
Pageof 7